Among all samples assayed via molecular testing (n = 260), ATM variants were detected in 15 of 159 circulating tumor cell DNA samples (9%), versus in 21 of 101 solid tumor biopsies (21%) (P = .010). This evidence concerns the gene ATM and neoplasm.